Author | Kleber Y. Fertrin, MD, PhD | OncLive

Author | Kleber Y. Fertrin, MD, PhD

Articles

Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP

July 30, 2019

Video

Kleber Y. Fertrin, MD, PhD, assistant professor, University of Washington School of Medicine, and hematology oncologist, Seattle Cancer Care Alliance, discusses the potential of fostamatinib (Tavalisse) in the treatment of patients with chronic immune thrombocytopenia (ITP).

Dr. Fertrin on the FDA Approval of Avatrombopag in ITP

July 02, 2019

Video

Kleber Y. Fertrin, MD, PhD, assistant professor, University of Washington School of Medicine, Seattle Cancer Care Alliance, discusses the FDA approval of avatrombopag in immune thrombocytopenia (ITP).

x